Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
Clinical trial NCT05001971 · COMPLETED
Trial details
- NCT number
- NCT05001971
- Sponsor
- Hunan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-30
- Primary completion
- 2025-01-21
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.